Heart disease diagnostics firm receives $30m investment

Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest are the main investors injecting nearly $30 million into MedTrace, a company specialising in the diagnosis of heart diseases.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: